MX2009009761A - Composiciones y estuches para tratamiento de la influenza. - Google Patents

Composiciones y estuches para tratamiento de la influenza.

Info

Publication number
MX2009009761A
MX2009009761A MX2009009761A MX2009009761A MX2009009761A MX 2009009761 A MX2009009761 A MX 2009009761A MX 2009009761 A MX2009009761 A MX 2009009761A MX 2009009761 A MX2009009761 A MX 2009009761A MX 2009009761 A MX2009009761 A MX 2009009761A
Authority
MX
Mexico
Prior art keywords
kits
compositions
treating influenza
influenza
treating
Prior art date
Application number
MX2009009761A
Other languages
English (en)
Inventor
Gregory T Went
Timothy J Fultz
Jack Nguyen
Paul Spence
David Chernoff
Original Assignee
Adamas Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamas Pharmaceuticals Inc filed Critical Adamas Pharmaceuticals Inc
Publication of MX2009009761A publication Critical patent/MX2009009761A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Se presentan composiciones, estuches y métodos para el tratamiento o profilaxis de la influenza.
MX2009009761A 2007-03-13 2008-03-12 Composiciones y estuches para tratamiento de la influenza. MX2009009761A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US91801107P 2007-03-13 2007-03-13
US97809907P 2007-10-05 2007-10-05
US98979007P 2007-11-21 2007-11-21
US12/040,856 US7981930B2 (en) 2007-03-13 2008-02-29 Compositions and kits for treating influenza
PCT/US2008/056678 WO2008112775A1 (en) 2007-03-13 2008-03-12 Compositions and kits for treating influenza

Publications (1)

Publication Number Publication Date
MX2009009761A true MX2009009761A (es) 2009-11-26

Family

ID=39759997

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009761A MX2009009761A (es) 2007-03-13 2008-03-12 Composiciones y estuches para tratamiento de la influenza.

Country Status (16)

Country Link
US (3) US7981930B2 (es)
EP (2) EP2450040A3 (es)
JP (1) JP2010521480A (es)
KR (1) KR20090125821A (es)
CN (1) CN101835503A (es)
AR (1) AR065704A1 (es)
AT (1) ATE545418T1 (es)
AU (1) AU2008225156A1 (es)
BR (1) BRPI0809007A2 (es)
CA (1) CA2680664A1 (es)
ES (1) ES2379414T3 (es)
IL (1) IL200889A0 (es)
MX (1) MX2009009761A (es)
RU (1) RU2009137607A (es)
TW (1) TW200904399A (es)
WO (1) WO2008112775A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1845968A2 (en) 2004-11-24 2007-10-24 Neuromolecular Pharmaceuticals, Inc Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
WO2010095041A2 (en) * 2009-02-18 2010-08-26 Excrx (Singapore) Pte.Ltd. Compositions, methods, and kits for treating influenza viral infections
TWI496578B (zh) * 2009-10-08 2015-08-21 Aureo Co Ltd 流感病毒感染症的治療劑
KR20120106942A (ko) * 2009-10-30 2012-09-27 베링거 인겔하임 인터내셔날 게엠베하 Ｂｉ２０１３３５, 인터페론 알파 및 리바비린을 포함하는 ｈｃｖ 병용 치료요법을 위한 투여 용법
CN102883601A (zh) * 2009-12-02 2013-01-16 阿达玛斯医药公司 金刚烷胺组合物及其使用方法
AU2015202356B2 (en) * 2009-12-02 2017-02-23 Adamas Pharma, Llc Amantadine compositions and methods of use
US11161881B2 (en) * 2010-11-18 2021-11-02 Apeptico Forschung Und Entwicklung Gmbh Composition comprising a peptide and an inhibitor of viral neuraminidase
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
US8569255B2 (en) 2011-02-02 2013-10-29 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Post-exposure therapy of influenza A infections
TWI479153B (zh) * 2011-07-01 2015-04-01 Nat Univ Chung Hsing Screening kit for screening anti - influenza drugs and its screening method
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
RU2682049C2 (ru) * 2014-01-27 2019-03-14 Дженентек, Инк. Лечение вируса гриппа а h7n9
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement
CA2966195A1 (en) 2014-11-04 2016-05-12 Adamas Pharmaceuticals, Inc. Oral adamantine in the treatment of gait disorders in multiple sclerosis patients
FR3033701B1 (fr) 2015-03-19 2021-01-15 Univ Claude Bernard Lyon Nouvelles compositions antivirales pour le traitement de la grippe
MA43532A (fr) 2015-12-30 2018-11-07 Adamas Pharmaceuticals Inc Méthodes et compositions destinés au traitement de troubles liés à des crises épileptiques
TW202206081A (zh) * 2016-08-03 2022-02-16 美商派瑞泰Ｓｐｖ２有限公司 ９—胺甲基米諾四環素化合物及其用途
JP2020516634A (ja) * 2017-04-12 2020-06-11 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルス感染の処置方法および併用療法
AU2018320946A1 (en) 2017-08-24 2020-04-16 Adamas Pharma, Llc Amantadine compositions, preparations thereof, and methods of use
US20190247331A1 (en) 2018-02-15 2019-08-15 Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság Composition and method for treating neurological disease
US10213394B1 (en) 2018-02-15 2019-02-26 Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság Composition and method for treating neurological disease
US10213393B1 (en) 2018-02-15 2019-02-26 Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság Composition and method for treating neurological disease
WO2021007283A1 (en) * 2019-07-09 2021-01-14 Regents Of The University Of Minnesota Potentiation of antiviral nucleobases as rna virus therapy
US20230181509A1 (en) * 2020-03-31 2023-06-15 Diffusion Pharmaceuticals Llc The use of diffusion enhancing compounds for treatment of viral and bacterial induced respiratory disease

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
US6258585B1 (en) 1992-05-14 2001-07-10 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting influenza virus replication
US5824706A (en) * 1994-09-26 1998-10-20 Schinazi; Raymond F. Method, compositions, and apparatus for treating and preventing respiratory viral infections
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
WO2001045727A2 (en) 1999-12-20 2001-06-28 New Pharma Research Sweden Ab Stabilized veterinary compositions comprising more than one antiviral agent
US20020004046A1 (en) * 2000-05-03 2002-01-10 Johnson Leslie S. Combination therapy of respiratory diseases using antibodies
US6605302B2 (en) * 2001-07-17 2003-08-12 Osmotica Corp. Drug delivery device containing oseltamivir and an H1 antagonist
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
US20050170334A1 (en) 2002-03-13 2005-08-04 Toshifumi Mikayama Human monoclonal antibodies to influenza M2 protein and methods of making and using same
AU2003257285A1 (en) * 2002-07-25 2004-02-16 Micrologix Biotech Inc. Inhibitors of rna dependent rna polymerase and uses thereof
DE10300222A1 (de) * 2003-01-03 2004-07-15 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
DE10313636A1 (de) * 2003-03-26 2004-10-14 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Verwendung von Wirksubstanzen zur Vorbeuge oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
WO2007057436A2 (en) 2005-11-18 2007-05-24 Ares Trading S.A. Interferon in influenza
AU2007254215A1 (en) * 2006-05-19 2007-11-29 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of viral infections
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US20090326978A1 (en) * 2008-06-30 2009-12-31 Fultz Timothy J Emergency Preparations for an Epidemic

Also Published As

Publication number Publication date
ATE545418T1 (de) 2012-03-15
CA2680664A1 (en) 2008-09-18
EP2142192B1 (en) 2012-02-15
EP2142192A4 (en) 2010-04-28
AR065704A1 (es) 2009-06-24
BRPI0809007A2 (pt) 2014-09-16
US7981930B2 (en) 2011-07-19
KR20090125821A (ko) 2009-12-07
IL200889A0 (en) 2010-05-17
ES2379414T3 (es) 2012-04-25
US20090247481A1 (en) 2009-10-01
JP2010521480A (ja) 2010-06-24
EP2142192A1 (en) 2010-01-13
US7858660B2 (en) 2010-12-28
RU2009137607A (ru) 2011-04-20
EP2450040A2 (en) 2012-05-09
CN101835503A (zh) 2010-09-15
AU2008225156A1 (en) 2008-09-18
EP2450040A3 (en) 2012-08-29
TW200904399A (en) 2009-02-01
US20080227743A1 (en) 2008-09-18
US20110230432A1 (en) 2011-09-22
WO2008112775A1 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
EP2569434A4 (en) COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA
WO2007092622A3 (en) Compositions and methods for treating bone
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
IN2012DN03883A (es)
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
TR200906131T1 (tr) Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
MX2009009292A (es) Compuestos activos en ppar.
MX2009009290A (es) Compuestos activos en ppar.
MY184101A (en) Indoles
EA201171367A1 (ru) Винилиндазолильные соединения
MX2012011543A (es) Tratamiento de sarcoidosis empleando celulas madre placentarias.
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
IN2012DN00624A (es)
TNSN08400A1 (en) Organic compounds and their uses
TW200716088A (en) Formulations and methods for treating amyloidosis
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
MY159244A (en) Method of reducing intraocular pressure in humans
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
TNSN08496A1 (en) Aminothiazoles and their uses
WO2010037095A3 (en) Agents and methods for the treatment of cancer
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения